T. Makris

473 total citations
19 papers, 350 citations indexed

About

T. Makris is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Epidemiology. According to data from OpenAlex, T. Makris has authored 19 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 5 papers in Immunology and 3 papers in Epidemiology. Recurrent topics in T. Makris's work include Blood Pressure and Hypertension Studies (10 papers), Cardiovascular Health and Disease Prevention (3 papers) and Sodium Intake and Health (2 papers). T. Makris is often cited by papers focused on Blood Pressure and Hypertension Studies (10 papers), Cardiovascular Health and Disease Prevention (3 papers) and Sodium Intake and Health (2 papers). T. Makris collaborates with scholars based in Greece, United States and United Kingdom. T. Makris's co-authors include Costas Thomopoulos, Christodoulos Stefanadis, Costas Tsioufis, Vasilios Papademetriou, Helena Michalopoulou, V. Votteas, Ourania Papazachou, A. Hatzizacharias, P. Krespi and Michael Kyriakidis and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Hypertension and American Journal of Hypertension.

In The Last Decade

T. Makris

19 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Makris Greece 9 174 86 71 58 53 19 350
Paul M. Ridker United States 3 212 1.2× 39 0.5× 71 1.0× 37 0.6× 26 0.5× 3 367
Kiyomi Kisu Japan 9 69 0.4× 74 0.9× 87 1.2× 16 0.3× 12 0.2× 17 350
Jiang-Feng Ke China 11 57 0.3× 42 0.5× 38 0.5× 70 1.2× 27 0.5× 23 292
Christine Winzer Austria 14 123 0.7× 117 1.4× 323 4.5× 117 2.0× 38 0.7× 17 630
Marinka S. Post Netherlands 8 58 0.3× 60 0.7× 71 1.0× 23 0.4× 27 0.5× 8 395
Michael Ryalls United Kingdom 7 91 0.5× 59 0.7× 25 0.4× 12 0.2× 26 0.5× 10 318
M. Spaanderman Netherlands 15 145 0.8× 293 3.4× 388 5.5× 23 0.4× 54 1.0× 43 498
Johanna Brix Austria 11 45 0.3× 37 0.4× 74 1.0× 82 1.4× 23 0.4× 27 442
A. Souvatzoglou Greece 9 90 0.5× 92 1.1× 172 2.4× 31 0.5× 45 0.8× 21 526
Derek D. Sandeman United Kingdom 12 99 0.6× 33 0.4× 17 0.2× 41 0.7× 25 0.5× 22 405

Countries citing papers authored by T. Makris

Since Specialization
Citations

This map shows the geographic impact of T. Makris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Makris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Makris more than expected).

Fields of papers citing papers by T. Makris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Makris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Makris. The network helps show where T. Makris may publish in the future.

Co-authorship network of co-authors of T. Makris

This figure shows the co-authorship network connecting the top 25 collaborators of T. Makris. A scholar is included among the top collaborators of T. Makris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Makris. T. Makris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Katsi, Vasiliki, et al.. (2016). [PP.30.22] DYSLIPIDEMIA AND AGGRAVATED QUALITY OF LIFE IN HYPERTENSIVES. Journal of Hypertension. 34(Supplement 2). e313–e313. 1 indexed citations
2.
Papadopoulos, Dimitrios, Elias Sanidas, Nora Viniou, et al.. (2015). Cardiovascular Hypertensive Emergencies. Current Hypertension Reports. 17(2). 5–5. 32 indexed citations
3.
Katsi, Vasiliki, Charalampos Siristatidis, George Farmakides, et al.. (2015). Preeclampsia: What Does the Father Have to Do with It?. Current Hypertension Reports. 17(8). 60–60. 9 indexed citations
4.
Thomopoulos, Costas, Costas Tsioufis, Helena Michalopoulou, et al.. (2012). Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review. Journal of Human Hypertension. 27(3). 148–157. 95 indexed citations
5.
Papadopoulos, Dimitrios, Costas Thomopoulos, Iordanis Mourouzis, et al.. (2011). Masked hypertension unfavourably affects haemostasis parameters. Blood Pressure. 20(4). 218–221. 2 indexed citations
6.
Thomopoulos, Costas, Maria Daskalaki, Ourania Papazachou, et al.. (2010). Association of resistin and adiponectin with different clinical blood pressure phenotypes. Journal of Human Hypertension. 25(1). 38–46. 24 indexed citations
7.
Makris, T., Costas Thomopoulos, D.P. Papadopoulos, et al.. (2009). Association of Passive Smoking With Masked Hypertension in Clinically Normotensive Nonsmokers. American Journal of Hypertension. 22(8). 853–859. 38 indexed citations
8.
Papadopoulos, Dimitris, et al.. (2008). Antiendothelial cell antibody levels in patients with masked hypertension. International Journal of Cardiology. 130(3). 405–408. 4 indexed citations
9.
Papadopoulos, Dimitris, T. Makris, Δέσποινα Περρέα, et al.. (2008). Adiponectin – Insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension. Blood Pressure. 17(1). 50–54. 19 indexed citations
10.
Papadopoulos, D.P., Costas Thomopoulos, Δέσποινα Περρέα, et al.. (2008). Changes of Metalloproteinases Profile in Patients With Masked Hypertension. Angiology. 60(6). 757–762. 1 indexed citations
11.
Papadopoulos, Dimitrios, et al.. (2006). Antiendothelial Cell Antibody Levels in Healthy Normotensives with High Normal Blood Pressure. Clinical and Experimental Hypertension. 28(8). 663–667. 8 indexed citations
12.
Stergiou, George S., et al.. (2004). ADDITIVE EFFECTS OF AN ACE INHIBITOR VS. A CA ANTAGONIST VS. A DIURETIC IN HYPERTENSIVE PATIENTS UNCONTROLLED ON ANGIOTENSIN RECEPTOR BLOCKER MONOTHERAPY. Journal of Hypertension. 22(Suppl. 1). S68–S68. 2 indexed citations
13.
Stergiou, George S., et al.. (2004). ADDITIVE EFFECTS OF AN ACE INHIBITOR VS. A CA ANTAGONIST VS. A DIURETIC IN HYPERTENSIVE PATIENTS UNCONTROLLED ON ANGIOTENSIN RECEPTOR BLOCKER MONOTHERAPY. Journal of Hypertension. 22(Suppl. 2). S318–S318. 1 indexed citations
14.
Liapis, Christos D., John D. Kakisis, V. Papavassiliou, et al.. (2004). Hemostatic function and carotid artery disease.. PubMed. 23(1). 14–7. 1 indexed citations
15.
Makris, T.. (2003). Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan. American Journal of Hypertension. 16(5). A118–A118. 13 indexed citations
16.
Makris, T.. (2000). Resistance to activated protein C and FV Leiden mutation in patients with a history of acute myocardial infarction or primary hypertension. American Journal of Hypertension. 13(1). 61–65. 20 indexed citations
17.
Makris, T., P. Krespi, A. Hatzizacharias, et al.. (2000). Fibrinolytic/hemostatic variables in arterial hypertension: response to treatment with irbesartan or atenolol. American Journal of Hypertension. 13(7). 783–788. 71 indexed citations
18.
Triposkiadis, F., et al.. (1998). Left atrial systolic function is depressed in idiopathic and preserved in ischemic dilated cardiomyopathy. Journal of the American College of Cardiology. 31. 149–149. 2 indexed citations
19.
Makris, T., V. Votteas, Gregory P. Vyssoulis, et al.. (1996). Effect of Antihypertensive Treatment on Lipids and Fibrinogen: Greek Multicentre Study of Cilazapril. Cardiology. 87(6). 524–528. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul M. Ridker Breakdown of academic impact, for papers by Kiyomi Kisu Breakdown of academic impact, for papers by Jiang-Feng Ke Breakdown of academic impact, for papers by Christine Winzer Breakdown of academic impact, for papers by Marinka S. Post Breakdown of academic impact, for papers by Michael Ryalls Breakdown of academic impact, for papers by M. Spaanderman Breakdown of academic impact, for papers by Johanna Brix Breakdown of academic impact, for papers by A. Souvatzoglou Breakdown of academic impact, for papers by Derek D. Sandeman
Rankless by CCL
2026